Advent says interested only in friendly Stada deal: Reuters
Private equity firm Advent has no interest in a hostile approach to German generic drugmaker Stada Arzneimittel, a spokeswoman for Advent said on Monday.
27 February 2017•1 min read
Private equity firm Advent has no interest in a hostile approach to German generic drugmaker Stada Arzneimittel, a spokeswoman for Advent said on Monday.
Hg agrees to back new European AI transformation firm alongside Anthropic
6 minutes ago · 1 min read
KKR-backed CIRCOR agrees to acquire Italian pump maker Green Silence Group
11 minutes ago · 1 min read
Benford Capital-backed RM Young acquires rain sensor maker Texas Electronics
33 minutes ago · 1 min read
Nexus Capital Management acquires Coldwater Creek parent from Newtimes Group
37 minutes ago · 1 min read
Platinum Equity acquires Warren Valve from Allied Group in carve-out deal
41 minutes ago · 2 mins read
Verdane leads growth round in German cybersecurity firm Enginsight
56 minutes ago · 2 mins read
AE Industrial Partners closes $850m Blue Raven continuation vehicle led by Lexington
1 hour ago · 1 min read
